Market Overview

THRX Initiated With Overweight At Piper Jaffray


Analysts at Piper Jaffray initiate coverage of Theravance (NASDAQ: THRX) with an "overweight" rating. The target price for THRX is set to $16.

TRRX gained 1.81% to close at $12.97 on Friday. More Analyst Ratings here

Posted-In: Piper JaffrayEarnings Long Ideas Initiation Markets Analyst Ratings Trading Ideas


Related Articles (THRX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters